نتایج جستجو برای: vivax

تعداد نتایج: 4808  

Journal: :Antimicrobial agents and chemotherapy 2008
U Lek-Uthai R Suwanarusk R Ruengweerayut T S Skinner-Adams F Nosten D L Gardiner P Boonma K A Piera K T Andrews B Machunter J S McCarthy N M Anstey R N Price B Russell

Recent studies using laboratory clones have demonstrated that several antiretroviral protease inhibitors (PIs) inhibit the growth of Plasmodium falciparum at concentrations that may be of clinical significance, especially during human immunodeficiency virus type 1 (HIV-1) and malaria coinfection. Using clinical isolates, we now demonstrate the in vitro effectiveness of two HIV-1 aspartic PIs, s...

2017
Xavier C Ding Maria Paz Ade J Kevin Baird Qin Cheng Jane Cunningham Mehul Dhorda Chris Drakeley Ingrid Felger Dionicia Gamboa Matthias Harbers Socrates Herrera Naomi Lucchi Alfredo Mayor Ivo Mueller Jetsumon Sattabongkot Arsène Ratsimbason Jack Richards Marcel Tanner Iveth J González

The global prevalence of malaria has decreased over the past fifteen years, but similar gains have not been realized against Plasmodium vivax because this species is less responsive to conventional malaria control interventions aimed principally at P. falciparum. Approximately half of all malaria cases outside of Africa are caused by P. vivax. This species places dormant forms in human liver th...

2018
Tsutomu Akama Yong-Kang Zhang Yvonne R. Freund Pamela Berry Joanne Lee Eric E. Easom Robert T. Jacobs Jacob J. Plattner Michael J. Witty Rosemary Peter Tim G. Rowan Kirsten Gillingwater Reto Brun Bakela Nare Luke Mercer Musheng Xu Jiangong Wang Hao Liang

Novel l-valinate amide benzoxaboroles and analogues were designed and synthesized for a structure-activity-relationship (SAR) investigation to optimize the growth inhibitory activity against Trypanosoma congolense (T. congolense) and Trypanosoma vivax (T. vivax) parasites. The study identified 4-fluorobenzyl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-l-valinate (5, AN1173...

2012
Florian Noulin Céline Borlon Peter van den Eede Luc Boel Catherine M. Verfaillie Umberto D’Alessandro Annette Erhart

The development of a system for the continuous culture of Plasmodium vivax in vitro would benefit from the use of reticulocytes derived from differentiated hematopoietic stem cells (HCS). At present, the need to use both fresh reticulocytes and fresh P. vivax isolates represents a major obstacle towards this goal, particularly for laboratories located in non-endemic countries. Here, we describe...

2016
Michael T. White Shunmay Yeung Edith Patouillard Richard Cibulskis

The continued success of efforts to reduce the global malaria burden will require sustained funding for interventions specifically targeting Plasmodium vivax The optimal use of limited financial resources necessitates cost and cost-effectiveness analyses of strategies for diagnosing and treating P. vivax and vector control tools. Herein, we review the existing published evidence on the costs an...

2014
Weimin Liu Yingying Li Katharina S. Shaw Gerald H. Learn Lindsey J. Plenderleith Jordan A. Malenke Sesh A. Sundararaman Miguel A. Ramirez Patricia A. Crystal Andrew G. Smith Frederic Bibollet-Ruche Ahidjo Ayouba Sabrina Locatelli Amandine Esteban Fatima Mouacha Emilande Guichet Christelle Butel Steve Ahuka-Mundeke Bila-Isia Inogwabini Jean-Bosco N. Ndjango Sheri Speede Crickette M. Sanz David B. Morgan Mary K. Gonder Philip J. Kranzusch Peter D. Walsh Alexander V. Georgiev Martin N. Muller Alex K. Piel Fiona A. Stewart Michael L. Wilson Anne E. Pusey Liwang Cui Zenglei Wang Anna Färnert Colin J. Sutherland Debbie Nolder John A. Hart Terese B. Hart Paco Bertolani Amethyst Gillis Matthew LeBreton Babila Tafon John Kiyang Cyrille F. Djoko Bradley S. Schneider Nathan D. Wolfe Eitel Mpoudi-Ngole Eric Delaporte Richard Carter Richard L. Culleton George M. Shaw Julian C. Rayner Martine Peeters Beatrice H. Hahn Paul M. Sharp

Plasmodium vivax is the leading cause of human malaria in Asia and Latin America but is absent from most of central Africa due to the near fixation of a mutation that inhibits the expression of its receptor, the Duffy antigen, on human erythrocytes. The emergence of this protective allele is not understood because P. vivax is believed to have originated in Asia. Here we show, using a non-invasi...

Journal: :Antimicrobial agents and chemotherapy 2003
Bruce M Russell Rachanee Udomsangpetch Karl H Rieckmann Barbara M Kotecka Russell E Coleman Jetsumon Sattabongkot

The aim of this study was to develop a simple, field-practical, and effective in vitro method for determining the sensitivity of fresh erythrocytic Plasmodium vivax isolates to a range of antimalarials. The method used is a modification of the standard World Health Organization (WHO) microtest for determination of P. falciparum drug sensitivity. The WHO method was modified by removing leukocyte...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2005
Ananias A Escalante Omar E Cornejo Denise E Freeland Amanda C Poe Ester Durrego William E Collins Altaf A Lal

The high prevalence of Duffy negativity (lack of the Duffy blood group antigen) among human populations in sub-Saharan Africa has been used to argue that Plasmodium vivax originated on that continent. Here, we investigate the phylogenetic relationships among 10 species of Plasmodium that infect primates by using three genes, two nuclear (beta-tubulin and cell division cycle 2) and a gene from t...

2013
Surendra K. Prajapati Hema Joshi Jane M. Carlton M. Alam Rizvi

The evolutionary history and age of Plasmodium vivax has been inferred as both recent and ancient by several studies, mainly using mitochondrial genome diversity. Here we address the age of P. vivax on the Indian subcontinent using selectively neutral housekeeping genes and tandem repeat loci. Analysis of ten housekeeping genes revealed a substantial number of SNPs (n = 75) from 100 P. vivax is...

2013
Abbas SHAHBAZI Pegah FARHADI Masoud YERIAN Ahad BAZMANI Sara KHADEM NAKHJIRI Arash RASOULI Ahmad RAEISI

BACKGROUND Plasmodium vivax is the most widespread species of Plasmodium in humans and causing about 80 million clinical cases annually. This study was undertaken to detect P. vivax in asymptomatic treated vivax malaria patients to trace latent/sub-patent malaria infection. METHOD The venous blood of all detected cases with P. vivax in Bashagard, Minab and Roodan Districts in Hormozgan Provin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید